ChrysCapital's Significant Stake Sale in GeBBS Healthcare to EQT

ChrysCapital Enters Agreement with EQT for GeBBS Healthcare Stake Sale

ChrysCapital, a prominent private equity fund, has finalized an agreement to sell a controlling beneficial interest in GeBBS Healthcare Solutions, known for its revenue cycle management (RCM) and risk adjustment services, to EQT, a leading global investment firm. This development was first reported on September 5, following Moneycontrol's updates on EQT outpacing rival suitor HillHouse in this acquisition.

The Market Landscape

Established in 2005, GeBBS has positioned itself as a technology-driven solution provider to hospital systems and payers across the US. The company has developed innovative technologies aimed at optimizing workflows, enhancing financial outcomes, ensuring compliance, and improving patient experiences.

• The US healthcare market requires substantial RCM investment.
• Research indicates the RCM services outsourcing market could reach $28 billion, with an 8-9% CAGR.
• GeBBS benefits from rising cost pressures and the talent shortage.

ChrysCapital acquired GeBBS Healthcare in 2018, playing a crucial role in its transformation into a prominent healthcare technology entity.

Future Prospects and Leadership Insights

Milind Godbole, CEO and MD of GeBBS, expressed gratitude to ChrysCapital for its ongoing support during the company's global expansion and sees phenomenal potential with EQT as an investor.

Akshat Babbar from ChrysCapital recognized GeBBS as a leader in RCM, highlighting their focus on client engagement. He expressed confidence in the acquisition's positive trajectory for both the company and its workforce.

EQT's partner, Hari Gopalakrishnan, noted healthcare technology as a core investment strategy and anticipates substantial growth aligned with GeBBS’ ambitious goals.